Search Results - "Asadipooya, Kamyar"

Refine Results
  1. 1
  2. 2

    RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease by Kalantar Hormozi, Mohammadreza, Raj, Rishi, Lankarani, Kamran B., Asadipooya, Kamyar

    “…Objective. Fatty liver is a rising global health concern, significantly increasing the burden of health care cost. Nonalcoholic fatty liver disease (NAFLD) has…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Treatment of Iron-deficiency Anemia in Patients with Subclinical Hypothyroidism by Ravanbod, Mohammadreza, MD, Asadipooya, Kamyar, MD, Kalantarhormozi, Mohammadreza, MD, Nabipour, Iraj, MD, Omrani, Gholamhosein R., MD

    Published in The American journal of medicine (01-05-2013)
    “…Abstract Objective Subclinical hypothyroidism is a health state that is associated with hypercholesterolemia, infertility, iron-deficiency anemia, and poor…”
    Get full text
    Journal Article
  5. 5

    Bone Quality in CKD Patients: Current Concepts and Future Directions – Part I by Asadipooya, Kamyar, Abdalbary, Mohamed, Ahmad, Yahya, Kakani, Elijah, Monier-Faugere, Marie-Claude, El-Husseini, Amr

    Published in Kidney diseases (01-07-2021)
    “…Background: There is ample evidence that patients with CKD have an increased risk of osteoporotic fractures. Bone fragility is not only influenced by low bone…”
    Get full text
    Journal Article
  6. 6

    Delivery of Euthyroid Baby following Hyperthyroidism in Twin Gestation with Coexisting Complete Hydatidiform Mole by Asadipooya, Kamyar, Hager, Matthew, Uy, Edilfavia Mae, Raj, Rishi

    Published in Case reports in endocrinology (2019)
    “…Context. Gestational trophoblastic disease (GTD) is a rare complication of pregnancy, ranging from molar pregnancy to choriocarcinoma. Twin pregnancies with…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Bone Quality in Chronic Kidney Disease Patients: Current Concepts and Future Directions – Part II by Asadipooya, Kamyar, Abdalbary, Mohamed, Ahmad, Yahya, Kakani, Elijah, Monier-Faugere, Marie-Claude, El-Husseini, Amr

    Published in Kidney diseases (01-09-2021)
    “…Background: Patients with chronic kidney disease (CKD) have an increased risk of osteoporotic fractures, which is due not only to low bone volume and mass but…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Oncogenic osteomalacia secondary to glomus tumor by Raj, Rishi, Hasanzadeh, Samaneh, Dashtizadeh, Mitra, Kalantarhormozi, Mohammadreza, Vahdat, Katayoun, Dabbaghmanesh, Mohammad Hossein, Nabipour, Iraj, Ravanbod, Mohammdreza, Assadi, Majid, Hashemi, Basir, Asadipooya, Kamyar

    “…Summary Oncogenic osteomalacia secondary to glomus tumor is extremely rare. Localization of causative tumors is critical as surgical resection can lead to a…”
    Get full text
    Journal Article
  12. 12

    Cardiovascular Outcomes of Romosozumab and Protective Role of Alendronate: A Conundrum or Clarification by Asadipooya, Kamyar, Weinstock, Ada

    “…Osteoporosis and cardiovascular diseases are major public health issues. Bone and cardiovascular remodeling share multiple biological markers and pathways…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature by Asadipooya, Kamyar, Uy, Edilfavia Mae

    Published in Journal of the Endocrine Society (01-10-2019)
    “…Abstract Diabetes compromises bone cell metabolism and function, resulting in increased risk of fragility fracture. Advanced glycation end products (AGEs)…”
    Get full text
    Journal Article
  16. 16

    Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review by Asadipooya, Kamyar, Asadipooya, Artin, Adatorwovor, Reuben

    Published in Archives of virology (01-06-2024)
    “…Coronavirus disease 2019 (COVID-19) is still causing hospitalization and death, and vaccination appears to become less effective with each emerging variant…”
    Get full text
    Journal Article
  17. 17

    Cardiovascular Outcomes of Romosozumab and Protective Role of Alendronate by Asadipooya, Kamyar, Weinstock, Ada

    “…Osteoporosis and cardiovascular diseases are major public health issues. Bone and cardiovascular remodeling share multiple biological markers and pathways…”
    Get full text
    Journal Article
  18. 18

    Type 1 Diabetes and COVID-19: A Literature Review and Possible Management by Kashfi, Kebria, Anbardar, Narges, Asadipooya, Artin, Asadipooya, Kamyar

    “…Context: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection normally damages the respiratory system but might likewise impair endocrine…”
    Get full text
    Journal Article
  19. 19

    Secondary Osteoporosis and Metabolic Bone Diseases by Sobh, Mahmoud M, Abdalbary, Mohamed, Elnagar, Sherouk, Nagy, Eman, Elshabrawy, Nehal, Abdelsalam, Mostafa, Asadipooya, Kamyar, El-Husseini, Amr

    Published in Journal of clinical medicine (24-04-2022)
    “…Fragility fracture is a worldwide problem and a main cause of disability and impaired quality of life. It is primarily caused by osteoporosis, characterized by…”
    Get full text
    Journal Article
  20. 20

    Endocrine manifestations of systemic mastocytosis in bone by Greene, Loren Wissner, Asadipooya, Kamyar, Corradi, Patricia Freitas, Akin, Cem

    Published in Reviews in endocrine & metabolic disorders (01-09-2016)
    “…Systemic Mastocytosis (SM) is characterized by accumulation of clonal, neoplastic proliferations of abnormal mast cells (MC) in one or more organ system other…”
    Get full text
    Journal Article Book Review